Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Forde

Showing results (31-40 of 307) with videos related to

Pageof 31
Sort By:
Expert Review of Anticancer Therapy|June 19, 2013
Targeted therapy for non-small-cell lung cancer: past, present and futurePatrick M Forde, David S Ettinger
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2020
Another Brick in the Wall: Sintilimab Plus Chemotherapy in Advanced Lung CancerVincent K Lam, Patrick M Forde
Clinical Advances in Hematology & Oncology : H&O|October 2, 2020
Immunotherapy for mesothelioma: rationale and new approachesJoshua E Reuss, Patrick M Forde
Journal of Bioscience and Bioengineering|January 25, 2008
Growth medium selection and its economic impact on plasmid DNA productionMichael K Danquah, Gareth M Forde
Journal of Medical Case Reports|July 2, 2011
Asystole following positive pressure insufflation of right pleural cavity: a case reportKari M Forde-Thielen, Mojca R Konia
American Family Physician|September 16, 2024
Hair Loss: Diagnosis and TreatmentMaryAnn Dakkak, Klive M Forde, Howard Lanney
Biotechnology and Bioengineering|July 23, 2008
Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomizationJenny Ho, Huanting Wang, Gareth M Forde
Autoimmunity|October 1, 1998
Anti-phagocyte antibodies and infectionA M Forde, C Feighery, J Jackson
The New England Journal of Medicine|November 19, 2025
Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. ReplyPatrick M Forde, Mariano Provencio, Nicolas Girard
British Journal of Biomedical Science|August 7, 1999
Characterisation of anti-neutrophil cytoplasmic antibody target antigens using electrophoresis and western blotting techniquesA M Forde, C Feighery, J Jackson
Pageof 31

Showing results (31-40 of 307) with videos related to

Sort By:
Pageof 31
Expert Review of Anticancer Therapy|June 19, 2013
Targeted therapy for non-small-cell lung cancer: past, present and futurePatrick M Forde, David S Ettinger
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2020
Another Brick in the Wall: Sintilimab Plus Chemotherapy in Advanced Lung CancerVincent K Lam, Patrick M Forde
Clinical Advances in Hematology & Oncology : H&O|October 2, 2020
Immunotherapy for mesothelioma: rationale and new approachesJoshua E Reuss, Patrick M Forde
Journal of Bioscience and Bioengineering|January 25, 2008
Growth medium selection and its economic impact on plasmid DNA productionMichael K Danquah, Gareth M Forde
Journal of Medical Case Reports|July 2, 2011
Asystole following positive pressure insufflation of right pleural cavity: a case reportKari M Forde-Thielen, Mojca R Konia
American Family Physician|September 16, 2024
Hair Loss: Diagnosis and TreatmentMaryAnn Dakkak, Klive M Forde, Howard Lanney
Biotechnology and Bioengineering|July 23, 2008
Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomizationJenny Ho, Huanting Wang, Gareth M Forde
Autoimmunity|October 1, 1998
Anti-phagocyte antibodies and infectionA M Forde, C Feighery, J Jackson
The New England Journal of Medicine|November 19, 2025
Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. ReplyPatrick M Forde, Mariano Provencio, Nicolas Girard
British Journal of Biomedical Science|August 7, 1999
Characterisation of anti-neutrophil cytoplasmic antibody target antigens using electrophoresis and western blotting techniquesA M Forde, C Feighery, J Jackson
Pageof 31